Westhouse Medical Services Plc Announces Appointment of New Member to its Medical Advisory Panel

LONDON, April 3, 2012 /PRNewswire/ --

Healthcare specialist Westhouse Medical Services Plc ("Ticker Symbol 5WM") today announces, with immediate effect, the appointment of Dr. Michael Sevenoaks as a member to its Medical Advisory Panel.

Dr Michael Sevenoaks BSc (Hons), MBBS, MRCGP, DRCOG, DFFP qualified as a doctor from St Georges Hospital Medical School, London, holding training posts in a variety of hospital medical and surgical specialties in London and the Home Counties as well as spending a year as a surgical registrar in Australia. He completed his General Practice training in Chichester and subsequently joined ICP, one of the largest group practices in the UK, where he now holds the position of Executive Partner.

He is a director of Epsomedical, an independent chain of day surgery units providing diagnostic and treatment services for the NHS and private sectors.

In addition to his medical interests, Michael also holds a first class honours degree in Biomedical Sciences and has published research in the field of cell and molecular biology, and maintains an active role in clinical trials and medical research.

Jack Kaye, founder and CEO of Westhouse Medical Services, commented: "We are pleased to welcome Dr Sevenoaks on to the Westhouse Medical Advisory Panel. He brings a wealth of experience to the company in the fields of medical research and clinical trials, which will be invaluable to us as we continue our acquisitive growth internationally within the healthcare sector."  

Westhouse is currently developing a number of medical  devices, including  BreastCheck - a new low-cost, non-invasive breast cancer screening product which can act as a precursor to mammogram scanning. BreastCheck is due for launch in summer 2012.

Westhouse recently entered into negotiations for the acquisition of a majority stake in US listed Sunridge International. Sunridge's subsidiary, Ophthalmic International Inc., has developed a glaucoma procedure called PNT, which could revolutionise the way glaucoma is treated globally.

WESTHOUSE MEDICAL SERVICES PLC  
SYMBOL: 5WM
WKN: A1JKH7
ISIN: GB00B6YWDK49
SEDOL: B6YWDK4

For press information, contact:
Jo Lee / Sian Edwards/ George Baggaley  
Chameleon PR
Email: westhouse@chameleonpr.com
Ph: +44(0)207-680-5500